How to Get GLP-1 Patients as a PMHNP

You’ve probably noticed: your patients keep asking about Ozempic. The ones who gained 40 pounds on Seroquel. The ones scrolling Instagram seeing before-and-after photos. The ones who’ve tried every diet and are desperate for something that actually works.

Here’s what most psychiatrists don’t realize: you’re sitting on a goldmine of untapped patient demand, and you’re uniquely positioned to meet it.

By 2025, an estimated 20 million Americans were actively taking GLP-1 medications for weight loss — a 600% increase in just six years. That’s not a trend. That’s a tidal wave. And while primary care docs are overwhelmed and obesity specialists are booked months out, psychiatrists have something nobody else brings to the table: expertise in behavior change, medication management, and the mental health side of weight loss that everyone else ignores.

The question isn’t whether there’s demand. The question is: how do you tap into it without adding another 20 hours to your workweek?

Why Psychiatrists Are Perfectly Positioned for GLP-1 Care

You’re Already Halfway There

A late-2023 survey found that nearly half of psychiatrists were already prescribing or recommending GLP-1 medications like Ozempic. Not because they suddenly became obesity medicine specialists, but because their patients needed it. Antipsychotics cause weight gain. Mood stabilizers cause weight gain. SSRIs can cause weight gain. You’re already managing the fallout — why not offer the solution?

Unlike a primary care doc seeing 30 patients a day who can barely squeeze in a diabetes check, you actually have time to talk to patients. You understand motivation. You know how to manage side effects. You’re comfortable with the ‘this might make you feel weird at first’ conversation because you have it every time you prescribe anything psychoactive.

And here’s the kicker: obesity is increasingly recognized as a disease with massive psychological components. Emotional eating. Binge eating disorder. Depression that kills motivation to exercise. Anxiety that drives comfort food. Your patients aren’t just fighting their metabolism — they’re fighting their mental health. That’s your lane.

The Patient Overlap Is Real

Look at your current caseload. How many patients have complained about weight gain from their meds? How many have comorbid obesity affecting their self-esteem, their energy, their willingness to leave the house? How many have binge eating patterns you’ve noted but didn’t have a tool to address beyond therapy referrals?

These are your first GLP-1 patients. You don’t need to go hunting for them — they’re already in your schedule. A PMHNP in California told me she started simply by mentioning to patients on antipsychotics: ‘I know the weight gain has been frustrating. There’s a medication that might help. Want to talk about it?’ Her weight management panel went from zero to 40 patients in four months, mostly from her existing practice.

Starting with current patients also means you’re not gambling on marketing spend. You’re not competing with the Hims and Hers of the world. You’re offering a service to people who already trust you, in the context of care you’re already providing.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

How to Actually Get GLP-1 Patients (Without Spending a Fortune on Marketing)

Start Internal: Convert Existing Patients

The lowest-hanging fruit is sitting in your EHR right now. Run a report: patients with BMI ≥30, or ≥27 with comorbidities (diabetes, hypertension, sleep apnea). That’s your FDA-approved criteria for GLP-1 weight loss medications.

At your next medication review with these patients, bring it up: ‘I know you’ve mentioned feeling frustrated about the weight gain from [medication]. I’ve started offering medical weight management that could help with that. Would you be interested in learning more?’

That’s it. No hard sell. Just opening the door.

Most will say yes. Some will book immediately. A few will think about it and circle back in three months when they’re ready. You’re not adding appointments — you’re adding a billable service to appointments you’re already doing.

Join a Telehealth Platform (The Fast Track)

If you want volume without the headache of building your own funnel, join a platform. Companies like Klarity Health, Ro, and others have already spent millions on Facebook ads, Google rankings, and patient acquisition. They funnel pre-qualified, motivated patients directly to enrolled providers.

Here’s the economic reality: acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+ when you factor in everything — SEO consultant fees, Google Ads that burn $15-40 per click, directory subscriptions, no-shows from cold leads, and months of investment before you see results. Most solo providers don’t have the expertise or patience for this. SEO takes 6-12 months of consistent work before it generates meaningful patient flow. Google Ads for ‘weight loss doctor near me’ are expensive and most clicks don’t convert.

Klarity and similar platforms flip the model: you only pay when a qualified patient books with you. No upfront ad spend. No monthly subscriptions. No wasted budget on clicks that go nowhere. The platform handles patient acquisition, matching, and the telehealth infrastructure. You control your schedule and only see patients when you want them.

Think of it this way: instead of spending $3,000-5,000/month on marketing with uncertain ROI, you pay a standard fee per new patient lead — and you know exactly what your acquisition cost is because you only pay when someone actually shows up. That’s guaranteed ROI versus gambling on marketing channels you might not even know how to optimize.

These platforms also bring volume fast. Some providers report going from zero weight-loss patients to 30+ within their first month of joining. The trade-off? The platform takes a cut. But when you’re starting out or scaling, removing the patient acquisition risk entirely is often worth it.

Build Your Own Funnel (The Long Game)

If you want more control and better margins long-term, you can market independently. This works best if you’re patient and willing to invest upfront.

SEO and Content: Create a simple website with pages targeting ‘[Your City] GLP-1 Doctor’ or ‘Psychiatrist Weight Loss Management.’ Write blog posts answering common questions: ‘Can I take Ozempic if I’m on antidepressants?’ or ‘Managing weight gain from psychiatric medications.’ Google rewards helpful, specific content. This takes 6-12 months to gain traction, but once it does, you get organic traffic with no ongoing ad spend.

Social Media: Share patient success stories (with permission), education about obesity and mental health, before-and-after transformations. Instagram and TikTok are where patients are already researching GLP-1s. A psychiatrist posting ‘What I wish patients knew about Ozempic and mental health’ can go semi-viral and attract dozens of DMs.

Referral Relationships: Let local PCPs, endocrinologists, therapists, and dietitians know you’re offering this service. Most are drowning in patient requests and will happily refer overflow. A simple email: ‘I’m a psychiatrist now offering medical weight management including GLP-1 medications. If you have patients struggling with obesity who need medication management or have mental health considerations, I’d be happy to see them.’ Attach your contact info and fax number. Half will ignore it. A few will send you one patient. One or two will become consistent referral sources.

Directories: List yourself on Zocdoc, Healthgrades, and Psychology Today. Note: these charge monthly fees and you’re competing with hundreds of other providers. Zocdoc also charges $35-100+ per booking on top of subscription costs. The leads can be good, but the total monthly cost adds up. Weigh this against a pay-per-appointment platform model — if you’re paying $150/month for Zocdoc plus $50 per booking, you’re spending real money for uncertain volume. Some providers find directories work well in specific markets; others find them a waste.

The Hybrid Approach

Most successful psychiatrists scaling a GLP-1 practice use a mix: start with your existing patients to build experience and confidence, join a platform to ramp volume quickly, and simultaneously build your own SEO and referral network for long-term leverage. After 6-12 months, you can shift more toward your own funnel if margins matter, or stay on the platform if volume and convenience matter more.

Telehealth GLP-1 Prescribing: What You Actually Need to Know

The Good News: It’s Legal and Easy

GLP-1 medications are not controlled substances, which means the Ryan Haight Act’s in-person exam requirement doesn’t apply. You can prescribe semaglutide, tirzepatide, liraglutide, etc., via telehealth with no prior face-to-face visit required — as long as you conduct a proper video evaluation and meet the standard of care.

Psychiatrists (MD/DO) can prescribe GLP-1s in any state where they hold a license. Psychiatric nurse practitioners can as well, but must follow state scope-of-practice rules (more on that below).

You don’t need special certifications. You don’t need to be board-certified in obesity medicine. You just need to be licensed, competent, and willing to learn the basics of obesity pharmacotherapy.

State-by-State Reality Check

Here’s where it gets nuanced. Every state has different rules, especially for NPs:

California: You need a California license. Period. California is not part of the Interstate Medical Licensure Compact (IMLC), so out-of-state docs need full licensure to treat CA patients. PMHNPs in California currently need physician supervision, but AB 890 is changing that — by 2026, experienced NPs who’ve completed a three-year supervised period can practice independently as ‘104 NPs.’ Until then, you’ll need a collaborative agreement. California also requires patient consent for telehealth (document it in your chart).

Texas: Texas is in the IMLC, so physicians can use it for expedited licensing. But Texas is strict on NP/PA supervision — all APRNs and PAs need a Prescriptive Authority Agreement with a Texas-licensed physician. One MD can supervise up to seven APRNs/PAs. Telehealth is fully legal in Texas with no in-person requirement for non-controlled substances, but if you’re a PMHNP, you need that supervising doc in place.

Florida: Florida offers an out-of-state telehealth provider registration for physicians, which lets you treat Florida patients without full licensure (though you can’t prescribe Schedule IIs except in narrow cases). GLP-1s are non-controlled, so this works fine. PMHNPs in Florida need physician collaboration — Florida’s ‘autonomous practice’ law only applies to primary care NPs, not psych NPs.

New York: Not in the IMLC, so you need a New York license. But New York allows experienced NPs (3,600+ hours of practice) to work independently without a collaborative agreement. If you’re a PMHNP in NY who’s met that threshold, you can prescribe GLP-1s on your own.

Pennsylvania: In the IMLC for physicians, but all NPs need a collaborative agreement with a physician — no independent practice yet despite repeated legislative attempts. Pennsylvania recently joined the Nurse Licensure Compact, which may ease some multi-state logistics, but NPs still need state-specific APRN licenses and physician agreements to prescribe.

Illinois: In the IMLC for physicians. Illinois offers ‘Full Practice Authority’ for NPs after 4,000 hours of practice and 250 hours of additional education. FPA-certified NPs can prescribe independently, including controlled substances. It’s one of the more NP-friendly states, though you need to meet the requirements first.

The Standard of Care

Regardless of state, your telehealth GLP-1 consults need to meet the same standard as in-person care:

• Comprehensive history: weight history, diet, exercise habits, medical conditions, current medications, past weight-loss attempts
• Baseline vitals and labs: weight, BMI, blood pressure, A1c, fasting glucose, liver panel, thyroid if indicated
• Mental health screening: binge eating, depression, body image issues
• Informed consent: discuss risks, benefits, side effects, off-label use if applicable
• Treatment plan: medication choice, dosing schedule, lifestyle modifications, follow-up cadence

Document everything. Use templates to streamline this — most telehealth EHRs let you build intake forms and note templates. A thorough initial consult might take 30-45 minutes. Follow-ups are usually 15-20 minutes.

Mental Health Considerations

Here’s where your psychiatry background becomes your competitive advantage. In late 2023, there were reports of rare suicidal ideation possibly linked to GLP-1 drugs. By early 2026, the FDA reviewed the data and found no clear causal link, even directing removal of suicide warnings from labels. But the fact remains: weight loss, body image changes, and appetite suppression can affect mood and self-perception.

You’re trained to spot this. At every follow-up, ask about mood, anxiety, motivation, body image. If a patient reports feeling more depressed or developing restrictive eating patterns, you can intervene immediately — something a primary care doc might miss entirely.

Some early research even suggests GLP-1s might independently improve certain psychiatric symptoms, though the data is preliminary. The point is: you’re equipped to monitor both the physical and psychological aspects of weight loss in a way other prescribers aren’t.

Cash vs. Insurance: The Economic Reality

Most weight-loss telehealth practices favor cash-pay models, and there’s a good reason: insurance coverage for GLP-1s for obesity is terrible.

As of mid-2024, only 13 state Medicaid programs (including California and Pennsylvania) covered GLP-1s for weight loss. Most private insurers cover these drugs for diabetes but specifically exclude obesity indications. Medicare historically didn’t cover weight-loss drugs at all, though that may be changing — in late 2025, Medicare announced plans to pilot coverage in coming years.

The result? Most patients pay out-of-pocket for the medications themselves. Brand-name Wegovy can cost $1,300+ per month without insurance. Compounded semaglutide from legitimate pharmacies runs $200-400/month. Patients know this going in — they’re already committed to paying.

That makes a cash-pay service model attractive: charge patients directly for consultations (either per-visit or via monthly subscription packages) and let them handle medication costs separately. No prior authorizations. No claim denials. No waiting weeks for approval. Simple, predictable revenue.

The typical pricing structure:

• Initial consult: $150-300 (comprehensive evaluation, treatment plan)
• Follow-up visits: $75-150 per visit, monthly or every 6-8 weeks
• Subscription models: $150-250/month including consults, check-ins, educational resources

Alternatively, you can participate with insurance for the visits themselves. Bill standard E/M codes (99213/99214 for follow-ups, 99204/99205 for new patients) or Medicare’s G0447 code for obesity counseling. This widens access for patients who can’t afford self-pay visits, but brings the usual insurance headaches: documentation requirements, lower reimbursement ($80-120 per follow-up vs. $150 cash), and the hassle of credentialing.

Many providers go hybrid: cash for the first consult (since it’s lengthy and high-value), then offer patients the option of insurance billing for follow-ups if they have coverage. Be transparent about costs upfront. Patients appreciate clarity more than they appreciate rock-bottom pricing.

Scaling Your GLP-1 Practice Without Burning Out

The Workflow That Actually Works

Scaling means seeing more patients in less time without cutting corners. Here’s how:

Standardize everything. Create intake forms that gather comprehensive history before the first appointment. Use templated note documentation for common scenarios (starting GLP-1, titrating dose, managing nausea, celebrating 20-pound weight loss). Build order sets for baseline labs and refill protocols. Every minute you save on administrative work is a minute you can spend with patients or not working.

Batch your appointments. Don’t scatter GLP-1 patients throughout your schedule. Dedicate specific blocks — say, Tuesday and Thursday mornings — to weight management. This keeps you in the right headspace and makes it easier to maintain flow. Some psychiatrists do half-day GLP-1 clinics once or twice a week, keeping their regular psych practice separate. Others integrate fully. Choose what works for your brain.

Leverage your team. If you have support staff (MA, RN, health coach), delegate like crazy. Have them collect weights, blood pressures, and symptom questionnaires before visits. Let them handle routine patient questions via portal messaging (‘Is it normal to feel nauseous the first week?’ — yes, here’s what to do). Use health coaches or dietitians for lifestyle counseling, either one-on-one or in group sessions. You focus on medication decisions and complex cases.

Use technology intelligently. A good telehealth platform with integrated e-prescribing, messaging, and patient portals is non-negotiable. Automated appointment reminders cut no-shows. Patient apps that track weekly weights and send automated check-in prompts let you monitor progress passively — you only intervene if something looks off. Some practices even use AI chatbots for FAQs, freeing up staff time.

Group visits are your friend. Once you have a panel of GLP-1 patients, consider monthly group telehealth sessions for ongoing support and education. A 30-minute Zoom with 10-15 patients covers nutrition tips, managing side effects, motivation strategies, Q&A. Patients get community support (weight loss is isolating), you get efficiency. Bill appropriately for group visits where allowed, or offer them as a value-add to your program.

The Follow-Up Cadence

Initial phase (first 3 months): Monthly visits for dose titration and side effect management. This is the high-touch period.

Maintenance phase (months 4+): Every 6-8 weeks, or even quarterly if the patient is stable. Some practices do a hybrid model: monthly brief check-ins (10 minutes, via video or async messaging) with quarterly full visits.

You’ll find your rhythm. The key is not over-promising your availability. If patients expect you to respond to every message within an hour, you’ll burn out fast. Set boundaries: ‘I check messages twice a day, expect a response within 24 hours for non-urgent questions.’

Retention Strategies

GLP-1 therapy is long-term. Most patients stay on medication for a year or more, often indefinitely. That’s recurring revenue if you keep them engaged.

Provide ongoing value:

• Monthly newsletters with tips, recipes, success stories
• Access to a private Facebook group or online community
• Partnerships with dietitians or personal trainers (refer patients, maybe negotiate a commission or reciprocal referrals)
• Celebrate milestones: send a congratulatory message when a patient hits 10% body weight loss

The more patients feel supported beyond the prescription, the less likely they are to churn to a cheaper competitor.

Protecting Yourself from Burnout

Here’s the truth: the demand for GLP-1 treatment is so high that you could fill your schedule five times over if you wanted. But ‘could’ doesn’t mean ‘should.’

Set a cap on GLP-1 patients per week until you’ve dialed in your systems. Maybe start with 5-10 per week, then gradually increase to 20-30 as you get efficient. Don’t try to go from zero to hero overnight.

Schedule regular time off. Telehealth makes it easy to work from anywhere, which is great — but also means you might never truly disconnect. Block out vacation weeks in your calendar now and don’t book patients during them.

Join a community of practice. There are online forums and groups for providers doing obesity medicine. Sharing challenges and learning from others prevents isolation and gives you fresh ideas when you’re stuck.

Remember why you’re doing this. Yes, it’s lucrative. But more importantly, you’re helping people lose weight who’ve been failed by every other approach. You’re improving their metabolic health, their mental health, their quality of life. That’s the kind of work that sustains a career, not just a paycheck.

The Bottom Line

Getting GLP-1 patients as a psychiatrist isn’t hard. The demand is overwhelming. The barriers to entry are low. The fit with your existing skillset is natural.

The hard part is doing it sustainably — building systems that let you scale without sacrificing your sanity or your quality of care.

Start small. Test with your current patients. Join a platform to ramp volume if you want it. Build efficient workflows and lean on your team. Set boundaries and protect your time.

In 12 months, you could have a thriving weight-management practice generating an extra $10,000-20,000+ per month in revenue, helping hundreds of patients transform their lives, and positioning yourself as an expert in one of the fastest-growing areas of medicine.

Or you could keep doing what you’re doing and watch other psychiatrists capture that opportunity instead.

Your call.

Ready to join Klarity’s provider network and start seeing GLP-1 patients this month? We handle patient acquisition, provide the telehealth infrastructure, and connect you with pre-qualified patients in your state. You focus on care. We handle the rest. Learn more about becoming a Klarity provider.

Frequently Asked Questions

Can psychiatrists legally prescribe GLP-1 medications like Ozempic?

Yes. Psychiatrists (MD/DO) can prescribe GLP-1 medications in any state where they hold a medical license. These are not controlled substances, so there are no special restrictions. Psychiatric nurse practitioners can also prescribe them, provided they follow their state’s scope-of-practice rules (which may require physician collaboration in some states).

Do I need obesity medicine certification to prescribe GLP-1s?

No. While board certification in obesity medicine (ABOM) can be helpful, it’s not required. You just need to be competent in the basics: patient evaluation, medication dosing, side effect management, and lifestyle counseling. Many psychiatrists successfully manage GLP-1 patients with self-directed learning and mentorship.

Is it legal to prescribe GLP-1s via telehealth?

Yes. Since GLP-1 medications are not controlled substances, the Ryan Haight Act’s in-person exam requirement does not apply. You can establish a patient relationship and prescribe via telehealth as long as you conduct a proper evaluation (typically via video) and meet your state’s standard of care. You must be licensed in the patient’s state.

How much can I realistically earn adding GLP-1 services?

It depends on your volume and pricing model. In a cash-pay model, initial consults might be $200-300 and follow-ups $100-150. If you see 20 GLP-1 patients per month (10 new, 10 follow-ups), that’s roughly $4,000-5,000 in additional monthly revenue. Scale to 50+ patients and you’re looking at $10,000-20,000+ per month. Insurance reimbursement is lower but can still add meaningful revenue if you have volume.

What’s the time commitment for GLP-1 patients?

Initial consults take 30-45 minutes. Follow-ups are typically 15-20 minutes. Most patients need monthly visits for the first 3 months, then every 6-8 weeks after that. With efficient workflows, you can see 3-4 GLP-1 patients per hour during follow-up blocks.

How do I handle the mental health aspects of GLP-1 therapy?

This is where your psychiatry training shines. Screen for binge eating disorder, body dysmorphia, and mood disorders at intake. Monitor for mood changes or disordered eating patterns at follow-ups. Educate patients that rapid weight loss can affect self-perception and relationships. If concerns arise, you can address them immediately or coordinate with a therapist — something non-psych providers often miss entirely.

What if a patient develops side effects I’m not comfortable managing?

Common side effects (nausea, constipation, injection site reactions) are straightforward to manage with dose adjustments and supportive care. For rare serious issues (pancreatitis, gallbladder problems), refer to emergency care or gastroenterology just as you would for any medical complication. Build a referral network with PCPs and specialists for complex cases. Know your limits and consult when needed — that’s good medicine.

Should I offer compounded semaglutide or stick with FDA-approved brands?

Both have pros and cons. FDA-approved medications (Wegovy, Saxenda, Zepbound) have proven safety and efficacy but are expensive ($1,000-1,500/month without insurance). Compounded semaglutide is cheaper ($200-400/month) but requires vetting the pharmacy for quality and compliance. Many practices offer both options and let patients choose based on budget. If you use compounders, work with reputable 503B facilities and stay updated on FDA guidance.

How do I market my GLP-1 services without sounding like a med spa?

Emphasize the medical and psychological aspects. Position yourself as a psychiatrist offering comprehensive weight management that addresses both metabolic health and mental well-being. Use educational content (blog posts, videos) that explains the science, not just the results. Avoid before-and-after photos that look like aesthetic marketing. Focus on health outcomes: improved A1c, reduced cardiovascular risk, better quality of life.

Citations

1. Axios – ‘Just how many Americans are taking GLP-1s now’ – www.axios.com (May 27, 2025)

2. ConfectioneryNews – ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry’ – www.confectionerynews.com (October 20, 2025)

3. Time Magazine – ‘The Heavy Cost of Using Weight-Loss Drugs to Get Skinny’ – time.com (August 22, 2025)

4. Axios – ‘America’s doctors need more obesity medicine training’ – www.axios.com (May 28, 2024)

5. Axios – ‘States slow to cover GLP-1s for weight loss’ – www.axios.com (November 5, 2024)

Source:

• https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing#:~:text=More%20than%202,their%20original%20approved%20use
• https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/#:~:text=GLP,real%20number%20according%20to%20Kim
• https://forum.schizophrenia.com/t/psychiatrists-recommend-ozempic/311318#:~:text=Drugs%20pharmanewsintel
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=equivalent%20to%20in,FDA%2C%20pharmacy%2C%20and%20board%20alerts
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=,with%20chart%20review%2C%20plus%20meetings
• https://www.singleaimhealth.com/news/nurse-practitioner-collaborative-agreement-templates-50-state-guide#:~:text=In%20Pennsylvania%2C%20Certified%20Registered%20Nurse,the%20CRNP%20and%20the%20collaborating
• https://www.wheel.com/state-telehealth-regulations/florida#:~:text=Are%20There%20Online%20Prescription%20Restrictions,for%20Telehealth%20in%20Florida
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=most%20insurances%20cover%20the%20medication,A%20recent%20Annals%20of%20Internal
• https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss#:~:text=What%20they%20found%3A%20In%20all%2C,a%20primary%20concern%2C%20KFF%20found
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=But%20these%20medications%20were%20originally,diabetes%2C%20weight%20loss%20treatment%20is